MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) — RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS) announced that the United States Food and Drug Administration (FDA) agreed that RapidPulse can begin enrollment in an Investigational Device Exemption (IDE) study of its novel and precise cyclic aspiration system. This will allow U.S. and European patient enrollment in 2025 to commence in a study designed to demonstrate the RapidPulse patented method of precisely pulsed aspiration is safe and effective in the treatment of AIS. RapidPulse’s technology is a spin-out of Syntheon 2.0, LLC, an innovative medical device incubator with a long track record of successful exits.
Tag: stroke
Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke
OTTAWA, ON, Nov. 15, 2024 /PRNewswire/ – Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that it has entered into a know-how license agreement with Mayo Clinic to collaborate on the delivery of enhanced telestroke services in the…
TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
NANJING, China, Oct. 25, 2024 /PRNewswire/ — On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke Conference (WSC): brain cell protection combined with…
Remedy Pharmaceuticals Announces FDA Orphan Drug Designation Granted for the Treatment of Large Territory Acute Ischemic Stroke with CIRARA
NEW YORK, Oct. 22, 2024 /PRNewswire/ — Remedy Pharmaceuticals, a pioneer in stroke drug development, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted Orphan Drug Designation for CIRARA for the treatment of “large…
KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment
A First in the Middle East and North Africa
KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ — Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and…
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 5, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation…
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
Gosselies (Belgium), August 21, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies to prevent and treat thrombotic and inflammatory diseases, announces today that the DMC reviewed the data from the first 8 patients in a planned review of the ongoing BIRCH Phase 2a trial of BIOX-101 to prevent secondary damage after intracerebral hemorrhagic stroke (ICH).
MemorialCare’s Long Beach Medical Center and Saddleback Medical Center Nationally Recognized by the American Heart Association with Get with the Guidelines Gold Plus Awards
FOUNTAIN VALLEY, Calif., Aug. 20, 2024 /PRNewswire/ — MemorialCare’s Long Beach Medical Center and Saddleback Medical Center received the American Heart Association’s Get With The Guidelines® – Stroke Gold Plus quality achievement awards. Long Beach Medical Center also received the Get…
TeleSpecialists Revolutionizes Stroke Care with Launch of Innovative EMS Integration Service
EMS Integration to enhance door-to-needle times and elevate patient outcomes
FORT MYERS, Fla., July 16, 2024 /PRNewswire/ — TeleSpecialists, LLC, the nation’s largest inpatient provider of TeleStroke and TeleNeurology services, launches its EMS Integration service as an enhancement to its current neurology services. This new service will allow TeleSpecialists’ board-certified neurologists to expedite stroke treatment and improve patient outcomes.
TeleSpecialists introduces the EMS Integration service for EMS and local hospitals, to enhance patient care in telestroke and teleneurology. This program enables physicians to interact with EMS teams, and hospitals simultaneously during patient transport. Early teleneurology involvement reduces door-to-needle times by connecting a neurologist on-screen during transit to conduct essential tests. With improved efficiency and collaboration, patients can receive a CT scan immediately upon arrival at the hospital.
“At TeleSpecialists, we are dedicated to pioneering innovations that enhance patient care. Our EMS Integration service represents a major advancement in our ability to improve patient outcomes, particularly in stroke care,” said Nima Mowzoon, MD, MBA, CEO of TeleSpecialists. “By enabling real-time neurology consultations en route to the hospital, we can significantly expedite treatment times and save more lives. This initiative is a testament to our commitment to leveraging technology to deliver the highest quality care to our communities.”
The introduction of the EMS Integration program emphasizes the organization’s commitment to clinical collaboration and continuous improvement in stroke care. This program aims to establish seamless communication between EMS providers and TeleSpecialists to provide timely and effective care for stroke patients in diverse settings. By integrating EMS into its TeleNeurology processes, the company seeks to optimize the delivery of critical interventions and resources, ultimately improving patient outcomes.
The launch of the EMS Integration program at Oak Hill and Bayonet Point Hospital in Hernando County marks a significant milestone in expanding and enhancing TeleSpecialists’ services. With over 10 years of experience and over one million patients seen, this initiative underscores the company’s commitment to delivering improved outcomes to these communities.
About TeleSpecialists, LLCAs the leader in TeleStroke and TeleNeurology and a reliable provider of exceptional TelePsychiatry services in the US, we lead the industry with unmatched quality, scale, and expertise. We seamlessly integrate cutting-edge technology with compassionate care, always striving to preserve and enhance lives through our commitment to excellence.
SOURCE TeleSpecialists